24/04/2022.
The iToBoS project was presented at the 1st Spring Biophotonics Conference in Porto (OPORTO22), through the conference titled “Multimodal optical systems for the investigation of skin diseases”.
21/04/2022.
Solving increasingly complex real-world problems, continuously contributes to the success of deep neural networks (DNNs). DNNs have long been established in numerous machine learning tasks and for this have been significantly improved in the past decade.
20/04/2022.
The scientific work "Explainable AI Methods - A Brief Overview", with the support of iToBoS project, has been published.
19/04/2022.
The scientific work "ECQx: Explainability-Driven Quantization for Low-Bit and Sparse DNNs", with the support of iToBoS project, has been published.
15/04/2022.
In iToBoS, machine learning/ artificial intelligence is key to combine all the design and make the system really a standout product.
13/04/2022.
Melanoma has a poor prognosis with median survival of 6-9 months in the absence of timely diagnosis and treatment.
11/04/2022.
Intégrer l’intelligence artificielle au domaine médical, c’est se poser les bonnes questions, notamment au niveau éthique.
7/04/2022.
The second issue of the iToBoS newsletter was released!!
4/04/2022.
On March 30th, scientists from the International Agency for Research on Cancer published a study on the Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
1/04/2022.
iToBoS project aims to provide new opportunities and added value to society in terms of novel health solutions, patient care, innovation, technical improvements and economic development.